Edit |   |
---|---|
Product Name | Ponatinib |
Description | Ponatinib is a small molecule which can act as a Pan-Bcr-Abl and multikinase inhibitor. It is provided as a powder. This product acts on the following target types: Kinase. This product acts on the following biochemical pathways: Cytokine, Proliferation, AKT, ERK, PI3K, JAK/STAT. This product may be of interest in the following research areas and diseases: Cell migration, Infectious disease, Cancer. This product may act as a Coronavirus inhibitor: Suppresses cytokine storm in mouse models; Inhibits SARS-CoV-2 in cells. Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address. MW: 532.56 g/mol |
Size | 5 mg, 25 mg |
Concentration | n/a |
Applications | n/a |
Other Names | Ponatinib, 3-(2-Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-benzamide, AP-24534, 943319-70-8 |
Gene, Accession, CAS # | CAS: 943319-70-8 |
Catalog # | abx076868 |
Price | please inquire |
Order / More Info | Ponatinib from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950